Despite big sales drop, GlaxoSmithKline is betting on a strong return later this year with help from Shingrix

  • by
Despite big sales drop, GlaxoSmithKline is betting on a strong return later this year with help from Shingrix
nhigginsdunn
Wed, 04/28/2021 – 11:50